BRIEF-Brazil says received request from Bharat Biotech from local phase III Covaxin trials

BRIEF-Brazil says received request from Bharat Biotech from local phase III Covaxin trials
  • Country:
  • Brazil

RIO DE JANEIRO, Feb 5 (Reuters) -

* BRAZILIAN HEALTH REGULATOR ANVISA SAYS HAS RECEIVED REQUEST FROM BHARAT BIOTECH TO CONDUCT PHASE III TRIALS OF COVAXIN VACCINE IN BRAZIL

*

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.